
GT Biopharma, Inc.
GTBPHealthcare|Biotechnology|US
$4.42
-0.12 (-2.64%)
DCF Value
$27.76
Tangible Book / Share
$2.30
Cash / Share
$3.19
Next Earnings Report
Nov 13, 2026
EPS est. -$2.50
Financing Filings (last 12 months)
8
Shelf registrations / offering prospectuses — latest Oct 20, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (1)
Jan 2031
Est. completion
Recent Press Releases
GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting
Oct 26, 2026 · GlobeNewsWire
GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma
Sep 15, 2026 · GlobeNewsWire
GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026
Sep 11, 2026 · GlobeNewsWire
GT Biopharma Reports Second Quarter 2026 Financial Results
Aug 14, 2026 · GlobeNewsWire
SEC Filings (74)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 20, 2026 | EFFECT | DocumentIndex | |
| Oct 20, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Oct 13, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Oct 9, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Oct 2, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Sep 29, 2026 | D | DocumentIndex | |
| Sep 25, 2026 | 8-K | Material event | DocumentIndex |
| Sep 21, 2026 | 8-K | Material event | DocumentIndex |
| Sep 15, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Sep 15, 2026 | 8-K | Material event | DocumentIndex |
| Sep 3, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 2, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 18, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 12, 2026 | 8-K | Material event | DocumentIndex |
| May 22, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 13, 2026 | EFFECT | DocumentIndex | |
| May 13, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Apr 30, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Apr 7, 2026 | 8-K | Material event | DocumentIndex |
| Mar 6, 2026 | 10-Q/A | Quarterly report | DocumentIndex |
| Mar 6, 2026 | 10-Q/A | Quarterly report | DocumentIndex |
| Mar 2, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 2, 2026 | 8-K | Material event | DocumentIndex |
| Jan 30, 2026 | EFFECT | DocumentIndex | |
| Jan 30, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jan 21, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Jan 8, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Dec 2, 2025 | EFFECT | DocumentIndex | |
| Dec 2, 2025 | 424B3 | Offering prospectus | DocumentIndex |
| Nov 26, 2025 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 14, 2025 | 8-K | Material event | DocumentIndex |
| Oct 24, 2025 | S-1 | IPO / offering registration | DocumentIndex |
| Sep 26, 2025 | 8-K | Material event | DocumentIndex |
| Sep 23, 2025 | 8-K | Material event | DocumentIndex |
| Aug 29, 2025 | 8-K | Material event | DocumentIndex |
| Aug 14, 2025 | 10-Q | Quarterly report | DocumentIndex |